Solution of the Drug Resistance Problem of Escherichia coli with Silver Nanoparticles: Efflux Effect and Susceptibility to 31 Antibiotics

The current work is a continuation of our studies focused on the application of nanoparticles of metallic silver (AgNPs) to address the global problem of antibiotic resistance. In vivo, fieldwork was carried out with 200 breeding cows with serous mastitis. Ex vivo analyses showed that after the cow was treated with an antibiotic-containing drug DienomastTM, E. coli sensibility to 31 antibiotics decreased by 27.3%, but after treatment with AgNPs, it increased by 21.2%. This could be explained by the 8.9% increase in the portion of isolates showing an efflux effect after DienomastTM treatment, while treatment with Argovit-CTM resulted in a 16.0% drop. We verified the likeness of these results with our previous ones on S. aureus and Str. dysgalactiae isolates from mastitis cows processed with antibiotic-containing medicines and Argovit-CTM AgNPs. The obtained results contribute to the recent struggle to restore the efficiency of antibiotics and to preserve the wide range of antibiotics on the world market.

[1]  P. Berraondo,et al.  Silver nanoparticles induce a non-immunogenic tumor cell death. , 2023, Journal of immunotoxicology.

[2]  N. Bogdanchikova,et al.  Silver Nanoparticles Targeting the Drug Resistance Problem of Streptococcus dysgalactiae: Susceptibility to Antibiotics and Efflux Effect , 2022, International journal of molecular sciences.

[3]  N. Bogdanchikova,et al.  AgNPs Targeting the Drug Resistance Problem of Staphylococcus aureus: Susceptibility to Antibiotics and Efflux Effect , 2022, Pharmaceutics.

[4]  J. Falconer,et al.  Nanomaterials: The New Antimicrobial Magic Bullet. , 2022, ACS infectious diseases.

[5]  Hongzhe Sun,et al.  Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Gayathri Harikumar,et al.  The growing menace of drug resistant pathogens and recent strategies to overcome drug resistance: a review , 2022, Journal of King Saud University - Science.

[7]  Z. Cui,et al.  Noble Metal-Based Nanomaterials as Antibacterial Agents , 2022, Journal of Alloys and Compounds.

[8]  P. Roncada,et al.  Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics , 2022, Antibiotics.

[9]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[10]  T. Amon,et al.  The Role of Streptococcus spp. in Bovine Mastitis , 2021, Microorganisms.

[11]  Porooshat Dadgostar,et al.  Antimicrobial Resistance: Implications and Costs , 2019, Infection and drug resistance.

[12]  S. Levy,et al.  Food Animals and Antimicrobials: Impacts on Human Health , 2011, Clinical Microbiology Reviews.